This topic contains a solution. Click here to go to the answer

Author Question: Sudden withdrawal of nitric oxide for inhalation (I-NO) can result in a rebound effect which can ... (Read 63 times)

tichca

  • Hero Member
  • *****
  • Posts: 554
Sudden withdrawal of nitric oxide for inhalation (I-NO) can result in a rebound effect which can result in which of the following?
 A) pneumothroaces
  B) overinflation
  C) pulmonary hypertension
  D) hyperoxemia

Question 2

Which of the following could cause an infant to be excluded from extracorporeal life support (ECLS)?
 A) a difference of greater than 620 torr for 6-12 hours
  B) gestational age of less than 35 weeks
  C) oxygen index of greater than 40 for 1-6 hours
  D) previous management with conventional mechanical ventilation for 2 days



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wshriver

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

C

Answer to Question 2

B




tichca

  • Member
  • Posts: 554
Reply 2 on: Jul 16, 2018
Great answer, keep it coming :)


ASDFGJLO

  • Member
  • Posts: 335
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

For a complete list of videos, visit our video library